Tortoise Media

Tortoise Media provides long-form journalism with a focus on in-depth analysis and slow news reporting. The site covers various topics, including politics, business, environment, and world news. The article analyzed focuses on the widespread use of Ozempic, a weight loss drug that has become increasingly popular in the United States.

98%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

95%

Examples:

  • The language used in the articles is highly positive and praising of Ozempic, with phrases like

Conflicts of Interest

100%

Examples:

  • There is no information provided about any conflicts of interest.

Contradictions

75%

Examples:

  • The article states that drug-makers can't keep up with rising demand for semaglutides while also mentioning that 15 million Americans currently use them. It also mentions the involvement of famous people like Oprah Winfrey and Elon Musk, alongside the fact that these drugs have noticeably slimmed down a country where 40% of the population is considered obese.

Deceptions

100%

Examples:

  • There are no examples of deceptive practices in the article.

Recent Articles

  • GLP-1 Agonists: The New Weight-Loss Drugs with Surprising Health Benefits and Potential Side Effects

    GLP-1 Agonists: The New Weight-Loss Drugs with Surprising Health Benefits and Potential Side Effects

    Broke On: Tuesday, 28 May 2024 New GLP-1 agonist weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have gained popularity for their health benefits beyond weight loss. These drugs reduce appetite and slow digestion while improving cardiovascular health and reducing the risk of diabetes and cancer. However, they come with potential side effects such as gastric issues, nausea, vomiting, muscle mass loss, osteoporosis, hair loss during rapid weight loss, and disrupted hair growth cycle.